TriAdeno Vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for TriAdeno Vaccine, covering 2026-04-06 to 2026-04-06. Get the full timeline:
Most recent: Clinical Trial Update: Phase I/II Study of the Combination Immunotherapy Regimen: SX-682, TriAdeno Vaccine, Retifanlimab and IL-15 Agonist N-803 (STAR15) for Metastatic Colorectal Cancer (mCRC) [Phase 1, Phase 2]